Intratumoral electroporation of IL-12 cDNA eradicates established melanomas by Trp2180–188-specific CD8+ CTLs in a perforin/granzyme-mediated and IFN-γ-dependent manner: application of Trp2180–188 peptides

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  2012-03-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00262-012-1214-8PMID 22382361PMCID PMC11028417
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice

  2011cited by this paper
• Interferon γ limits the effectiveness of melanoma peptide vaccines.

  2011cited by this paper
• Electrogene therapy with interleukin-12 in canine mast cell tumors

  2010cited by this paper
• Plasmid injection and application of electric pulses alter endogenous mRNA and protein expression in B16.F10 mouse melanomas

  2010cited by this paper
• Evaluation of delivery conditions for cutaneous plasmid electrotransfer using a multielectrode array

  2010cited by this paper
• Cancer electrogene therapy with interleukin-12.

  2010cited by this paper
• Adoptive transfer of human papillomavirus E7-specific CTL enhances tumor chemoresponse through the perforin/granzyme-mediated pathway.

  2009cited by this paper
• Local and systemic antitumor effect of intratumoral and peritumoral IL-12 electrogene therapy on murine sarcoma

  2009cited by this paper
• Suppression of antitumour protective cytotoxic T lymphocyte responses to a human papillomavirus 16 E7 DNA vaccine by coinjection of interleukin‐12 complementary DNA: involvement of nitric oxide in immune suppression

  2009cited by this paper
• Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.

  2008cited by this paper
• Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor.

  2008cited by this paper
• Therapeutic Synergy of Human Papillomavirus E7 Subunit Vaccines plus Cisplatin in an Animal Tumor Model: Causal Involvement of Increased Sensitivity of Cisplatin-Treated Tumors to CTL-Mediated Killing in Therapeutic Synergy

  2007cited by this paper
• Increased sensitivity of radiated murine cervical cancer tumors to E7 subunit vaccine-driven CTL-mediated killing induces synergistic anti-tumor activity.

  2007cited by this paper
• Antitumor Therapeutic Effects of E7 Subunit and DNA Vaccines in an Animal Cervical Cancer Model: Antitumor Efficacy of E7 Therapeutic Vaccines Is Dependent on Tumor Sizes, Vaccine Doses, and Vaccine Delivery Routes

  2006cited by this paper
• In vivo electrogene transfer of interleukin‐12 inhibits tumor growth and lymph node and lung metastases in mouse mammary carcinomas

  2006cited by this paper
• Optimization of a self antigen for presentation of multiple epitopes in cancer immunity.

  2006cited by this paper
• Administration route- and immune cell activation-dependent tumor eradication by IL12 electrotransfer.

  2005cited by this paper
• Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer

  2004cited by this paper
• [Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model].

  2002cited by this paper
• Both E7 and CpG-oligodeoxynucleotide are required for protective immunity against challenge with human papillomavirus 16 (E6/E7) immortalized tumor cells: involvement of CD4+ and CD8+ T cells in protection.

  2002cited by this paper
• IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma.

  2002influential reference
• In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice

  2001cited by this paper
• Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation.

  2001cited by this paper
• Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model.

  2001cited by this paper
• Intratumoral Delivery of Interleukin 12 Expression Plasmids with In Vivo Electroporation Is Effective for Colon and Renal Cancer

  2001cited by this paper
• Consequences of cell death: exposure to necrotic tumor cells

  2000cited by this paper
• Consequences of Cell Death

  2000cited by this paper
• IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge.

  1999cited by this paper
• In vivo priming by DNA injection occurs predominantly by antigen transfer.

  1999cited by this paper
• Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis.

  1998cited by this paper
• Effects of Single-Dose Interleukin-12 Exposure on Interleukin-12–Associated Toxicity and Interferon-γ Production

  1997cited by this paper
• Identification of Tyrosinase-related Protein 2 as a Tumor Rejection Antigen for the B16 Melanoma

  1997cited by this paper
• Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production.

  1997cited by this paper
• Identification of TRP-2 as a Human Tumor Antigen Recognized by Cytotoxic T Lymphocytes

  1996cited by this paper
• Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression.

  1995cited by this paper
• Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo.

  1994cited by this paper
• Interleukin‐12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells

  1993cited by this paper
• Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF

  1992cited by this paper
• Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

  1989cited by this paper

• Local delivery of IL-12 mRNA and indoximod prodrug potentiates antitumor immunity by increasing T cell effector function.

  2025cites this paper
• Dual cytokine-engineered macrophages rejuvenate the tumor microenvironment and enhance anti-PD-1 therapy in renal cell carcinoma.

  2025cites this paper
• Recombinant oncolytic adenovirus armed with CCL5, IL-12, and IFN-γ promotes CAR-T infiltration and proliferation in vivo to eradicate local and distal tumors

  2023cites this paper
• Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity

  2022cites this paper
• Intratumoral electroporation of plasmid encoded IL-12 and membrane-anchored anti-CD3 increases systemic tumor immunity.

  2022cites this paper
• Intratumoral DNA-based delivery of checkpoint-inhibiting antibodies and interleukin 12 triggers T cell infiltration and anti-tumor response

  2021cites this paper
• Clinical Applications and Immunological Aspects of Electroporation-Based Therapies

  2021cites this paper
• Local Destruction of Tumors and Systemic Immune Effects

  2021cites this paper
• B16 melanomas evade antitumor immunity by the loss of epitope presentation and the acquisition of tumor resistance to granzyme B.

  2021cites this paper
• B16 melanoma control by anti-PD-L1 requires CD8+ T cells and NK cells: application of anti-PD-L1 Abs and Trp2 peptide vaccines

  2021cites this paper
• Intratumoral Plasmid IL12 Expands CD8+ T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti–PD-1 Therapy

  2021influential citation
• Molecular and Macroscopic Therapeutic Systems for Cytokine‐Based Cancer Immunotherapy

  2021cites this paper
• YAP Attenuates CD8 T Cell-Mediated Anti-tumor Response

  2020cites this paper
• MHC Class I Molecules and Cancer Progression: Lessons Learned from Preclinical Mouse Models

  2020cites this paper
• CD8+ T Cells Directed Against a Peptide Epitope Derived From Peptidoglycan-Associated Lipoprotein of Legionella pneumophila Confer Disease Protection

  2020cites this paper
• Localized Interleukin-12 for Cancer Immunotherapy

  2020cites this paper
• Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment

  2020cites this paper
• T Cells and Regulated Cell Death: Kill or Be Killed.

  2019cites this paper
• Regulation of the translation activity of antigen-specific mRNA is responsible for antigen loss and tumor immune escape in a HER2-expressing tumor model

  2019cites this paper
• Characterization of abscopal effects of intratumoral electroporation-mediated IL-12 gene therapy

  2018cites this paper
• Truncated CD200 stimulates tumor immunity leading to fewer lung metastases in a novel Wistar rat metastasis model.

  2018cites this paper
• Improving therapeutic efficacy of IL-12 intratumoral gene electrotransfer through novel plasmid design and modified parameters

  2018cites this paper
• Therapeutic Tumor Control of HER2 DNA Vaccines Is Achieved by an Alteration of Tumor Cells and Tumor Microenvironment by Gemcitabine and Anti-Gr-1 Ab Treatment in a HER2-Expressing Tumor Model

  2017cites this paper
• Tumor regression is mediated via the induction of HER263-71- specific CD8+ CTL activity in a 4T1.2/HER2 tumor model: no involvement of CD80 in tumor control

  2017cites this paper
• Melanoma treatment with intratumoral electroporation of tavokinogene telseplasmid (pIL-12, tavokinogene telseplasmid).

  2017cites this paper
• Generation of MHC class I diversity in primary tumors and selection of the malignant phenotype

  2016cites this paper
• Gr upSM Antitumor Gene Immunotherapy in Melanoma

  2016cites this paper
• In-situ tumor vaccination: Bringing the fight to the tumor

  2015cites this paper
• DNA vaccines, electroporation and their applications in cancer treatment

  2015cites this paper
• Advanced Lung Cancer Is Associated with Decreased Expression of Perforin, CD95, CD38 by Circulating CD3+CD8+ T Lymphocytes.

  2015cites this paper
• A loss of antitumor therapeutic activity of CEA DNA vaccines is associated with the lack of tumor cells' antigen presentation to Ag-specific CTLs in a colon cancer model.

  2015cites this paper
• How Do Cytotoxic Lymphocytes Kill Cancer Cells?

  2015influential citation
• MC32 tumor cells acquire Ag-specific CTL resistance through the loss of CEA in a colon cancer model

  2015cites this paper
• Physical methods for gene transfer.

  2015cites this paper
• Early Tumor-Infiltrating Dendritic Cells Change their Characteristics Drastically in Association with Murine Melanoma Progression.

  2015cites this paper
• Early Tumor-Infiltrating Dendritic Cells Change their Characteristics Drastically in Association with Murine Melanoma Progression

  2015cites this paper
• New insights into IL-12-mediated tumor suppression

  2014cites this paper
• Induction of Bcl‐xL‐Specific Cytotoxic T Lymphocytes in Mice

  2014cites this paper
• SA-4-1BBL as a platform to develop adjuvant systems for prophylactic and therapeutic vaccines.

  2014cites this paper
• MHC Class I Antigens In Malignant Cells

  2013cites this paper
• MHC Class I Expression in Experimental Mouse Models of Cancer: Immunotherapy of Tumors with Different MHC-I Expression Patterns

  2013cites this paper
• Combined stimulation of TLR9 and 4.1BB augments Trp2 peptide vaccine-mediated melanoma rejection by increasing Ag-specific CTL activity and infiltration into tumor sites.

  2013cites this paper
• Effective Cooperation of Monoclonal Antibody and Peptide Vaccine for the Treatment of Mouse Melanoma

  2013cites this paper
• MHC Class I Antigens and the Tumor Microenvironment

  2013cites this paper
• Xiao-Ai-Ping, a TCM Injection, Enhances the Antigrowth Effects of Cisplatin on Lewis Lung Cancer Cells through Promoting the Infiltration and Function of CD8+ T Lymphocytes

  2013cites this paper
• Electroporation driven delivery of both an IL-12 expressing plasmid and cisplatin synergizes to inhibit B16 melanoma tumor growth through an NK cell mediated tumor killing mechanism

  2012cites this paper